Biosynergy Inc (BSYN) financial statements (2020 and earlier)

Company profile

Business Address 55 WEST MONROE STREET
CHICAGO, IL 60603
State of Incorp. IL
Fiscal Year End April 30
SIC 3829 - Measuring and Controlling Devices, Not Elsewhere Classified (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

10/31/2019
TTM
4/30/2019
4/30/2017
4/30/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1,2241,1801,0411,092
Cash and cash equivalents1,2241,1801,0411,092
Receivables242246268192
Inventory, net of allowances, customer advances and progress billings157163186109
Inventory157163186109
Other undisclosed current assets40583226
Total current assets:1,6631,6471,5271,419
Noncurrent Assets
Operating lease, right-of-use asset45
Property, plant and equipment9122015
Long-term investments and receivables 202020
Due from related parties 202020
Intangible assets, net (including goodwill)1121197079
Intangible assets, net (excluding goodwill)1121197079
Other undisclosed noncurrent assets6755647
Total noncurrent assets:172226166161
TOTAL ASSETS:1,8351,8731,6921,580
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities38262930
Accounts payable6545
Accrued liabilities 044
Employee-related liabilities31222222
Other undisclosed current liabilities551304239
Total current liabilities:931567269
Noncurrent Liabilities
Liabilities, other than long-term debt24   
Deferred income tax liabilities24
Total noncurrent liabilities:24   
Total liabilities:1171567269
Stockholders' equity
Stockholders' equity attributable to parent, including:1,7181,6921,5861,478
Retained earnings1,0771,051944837
Other undisclosed stockholders' equity attributable to parent641641641641
Total stockholders' equity:1,7181,6921,5861,478
Other undisclosed liabilities and equity 243532
TOTAL LIABILITIES AND EQUITY:1,8351,8731,6921,580

Income statement (P&L) ($ in thousands)

10/31/2019
TTM
4/30/2019
4/30/2017
4/30/2016
Revenues321,2931,338
Revenue, net1,2931,338
Other income32  
Cost of revenue
(Cost of Goods and Services Sold)
(416)(423)(376)(415)
Other undisclosed gross profit1,1721,289  
Gross profit:758869916923
Operating expenses(770)(769)(768)(778)
Operating income (loss):(12)100149145
Income (loss) from continuing operations before income taxes:(12)100149145
Income tax expense (benefit)3(29)(44)(41)
Net income (loss):(9)71105104
Other undisclosed net income attributable to parent3222
Net income (loss) available to common stockholders, diluted:(7)73107106

Comprehensive Income ($ in thousands)

10/31/2019
TTM
4/30/2019
4/30/2017
4/30/2016
Net income (loss):(9)71105104
Comprehensive income (loss), net of tax, attributable to parent:(9)71105104

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: